Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Ongentys as add-on treatment for patients with Parkinson's disease

April 28, 2020

Pivotal ADVANCE-1 study of AXS-05 meets primary endpoint

April 28, 2020

FDA grants IND approval for phase III study of GV-971 in Alzheimer's disease

April 28, 2020

NRF2 wakes sleeping tumor cells

April 28, 2020

Heart failure hormone has role in sepsis

April 28, 2020

Preliminary findings from phase II portion of U.S. phase II/III trial of Kevzara in COVID-19

April 27, 2020

New phase III trial to evaluate pacritinib in patients with severe COVID-19

April 27, 2020

Avadel reports pivotal phase III data on FT-218 in patients with narcolepsy

April 27, 2020

Phase III study of Libtayo in first-line NSCLC meets OS primary endpoint

April 27, 2020

Hua reports phase I data on dorzagliatin with empagliflozin in type 2 diabetes

April 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...